3Rajan L, Molitemo DJ. Beyond aspirin and clopidogrel: is there a need for additional antiplatelet therapy in ACS? J]. Curr Cardiol Rep, 2011,13 : 303-311. 被引量：1
6Hayward CP. Moffat KA,Spitzer E, et al. Results of an exter- nal proficiency testing exercise on platelet dense-granule defi- ciency testing by whole mount electron microscopy J]. Am J Clin Pathol, 2009,131 (5) : 671-675. 被引量：1
7Snoep JD, Hovens MM, Eikenboom JC, et al. Association of la- boratory-defined aspirin resistance with a higher risk of recur- rent cardiovascular events: a systematic review and meta-anal- ysisf_J. Arch Intern Med, 2007,167(15):1593-1599. 被引量：1
8Maeehi L, Christiaens L, Brabant S, et al. Resistance in vitro to Iow-dose aspirin is associated with platelet PIA1 (GPI]] a )poly- morphism but not wiII CS07T(GP la/lla)and C-5TKozak(GPI- baIpha) polymorphisms ]. J Am Coil Cardiol, 2003,42 (6) : 1115-1119. 被引量：1
9Cotter G, Shemesh E, Zehavi M, et al. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? [J]. Am Heart J, 2004,147 (2) : 293-300. 被引量：1
10Cox D, Maree AO, Dooley M, et al. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volun- teersf.J. Stroke, 2006,37 (8) : 2153-2158. 被引量：1
2Tanaka A,Kawarahayashi T,Nishibori Y,et al.No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction.Circulation,2002,105:2148-2152. 被引量：1
3Brosh D,Assali AR,Maser A,et al.Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality.Am J Cardiol 2007,99:442-445. 被引量：1
4Singh M,Mathew V,Garratt KN,et al.Effect of age on the outcome of angioplasty for acute myocardial infarction among patients treated at the Mayo Clinic.Am J Med,2000,108:187-192. 被引量：1
5Kirma C,Izgi A,Dundar C,et al.Clinical and Procedural Predictors of No-Reilow Phenomenon After Primary Percutaneous Coronary Interventions.Ciro J,2008,72:716-721. 被引量：1
6Isaaz K,Robin C,Cerisier A,et al.A new approach of primary angioplasty for ST-elevation acute myocardial infarction based on minimalist immediate mechanical intervention.Coron Artery Dis,2006,17:261-269. 被引量：1
7De Luca G,Ernst N,Zijlstra F,et al.Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty.J Am Coll Cardiol,2004,43:1363-1367. 被引量：1
8Lee DP,Herity NA,Hiatt BL,et al.Adjunctive platelet glycoprotein Ⅱb/Ⅲa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes.Circulation,2003,107:1497-1501. 被引量：1
9Zeymer U,Zahn R,Schiele R,et al.Early eptifibatide improves TIMI 3 pateacy before primary percutaneous coronary intervention for acute ST elevation myocardial infarction:Results of the randomized integtilin in acute myocardial infarction(INTAMI)pilot trial.Eur Heart J,2005,26:1971-1977. 被引量：1
10Iwakura K,Ito H,Nishikawa N,et al.Early temporal changes in coronary flow velocity pattern in patients with acute myocardial infarction demonstrating "no-reflow"phenomenon.Am J Cardiol,1999,84:415-419. 被引量：1
